5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 12,287.60▼ | 11,905.20▲ |
MA10 | N/A | N/A | N/A | 12,219.60▼ | 11,266.40▲ |
MA20 | N/A | N/A | N/A | 11,844.40▲ | 10,802.45▲ |
MA50 | N/A | N/A | N/A | 11,040.04▲ | 10,744.26▲ |
MA100 | N/A | N/A | N/A | 10,718.56▲ | 10,883.98▲ |
MA200 | N/A | N/A | N/A | 10,659.13▲ | 9,686.00▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -13.617▼ | 236.399▲ |
RSI | N/A | N/A | N/A | 69.421▲ | 69.344▲ |
STOCH | N/A | N/A | N/A | 72.826 | 90.779▲ |
WILL %R | N/A | N/A | N/A | -40.498 | -8.749▲ |
CCI | N/A | N/A | N/A | 16.959 | 131.483▲ |
Thursday, May 16, 2024 10:11 AM
Positive high-level results have been presented from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis (prevention) trial of AstraZeneca’s (LSE: AZN) sipavibart.
|
Thursday, May 16, 2024 06:03 AM
Deciding which shares are the best to invest in is important when considering long-term passive income. However, there are several factors to consider. The post To aim for £1,000 a month in passive ...
|
Sunday, May 12, 2024 11:20 PM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/05/24 | 12,240.00 | 12,306.00 | 12,132.00 | 12,172.00 | 1,286,395 |
14/05/24 | 12,324.00 | 12,406.00 | 12,246.00 | 12,246.00 | 1,150,481 |
13/05/24 | 12,326.00 | 12,428.00 | 12,259.204 | 12,318.00 | 1,214,305 |
10/05/24 | 12,350.00 | 12,432.00 | 12,313.76 | 12,370.00 | 987,268 |
09/05/24 | 12,268.00 | 12,388.00 | 12,254.04 | 12,332.00 | 881,913 |
08/05/24 | 12,244.00 | 12,384.00 | 12,228.00 | 12,264.00 | 1,459,803 |
07/05/24 | 11,966.00 | 12,162.00 | 11,966.00 | 12,118.00 | 1,303,688 |
03/05/24 | 12,092.00 | 12,178.00 | 12,010.00 | 12,050.00 | 1,440,455 |
02/05/24 | 12,114.00 | 12,258.00 | 12,114.00 | 12,156.00 | 1,689,308 |
01/05/24 | 12,194.00 | 12,266.00 | 12,054.00 | 12,170.00 | 645,985 |
|
|
||||
|
|
||||
|
|